Phosphatidic acid (PA) and phosphoinositides are metabolically interconverted lipid second messengers that have central roles in many growth factor (GF)-stimulated signalling pathways. Yet, little is known about the mechanisms that coordinate their production and downstream signalling. Here we show that the phosphatidylinositol (PI)-transfer protein Nir2 translocates from the Golgi complex to the plasma membrane in response to GF stimulation. This translocation is triggered by PA formation and is mediated by its C-terminal region that binds PA in vitro. We further show that depletion of Nir2 substantially reduces the PI(4,5)P2 levels at the plasma membrane and concomitantly GF-stimulated PI(3,4,5)P3 production. Finally, we show that Nir2 positively regulates the MAPK and PI3K/AKT pathways. We propose that Nir2 through its PA-binding capability and PI-transfer activity can couple PA to phosphoinositide signalling, and possibly coordinates their local lipid metabolism and downstream signalling.
mutants that consist of only the PI-transfer domain (PITD) or the C-terminal region (Cter) ( Fig 1A) . As shown, endogenous Nir2 ( Fig 1B) as well as ectopically expressed wild-type (WT) Nir2-Myc ( Fig 1C) localized mainly to the Golgi complex of HeLa cells. Deletion of the PITD, but not of the C-terminal region, markedly reduced its Golgi localization. Furthermore, the PITD fused to green fluorescent protein (GFP) was localized in the Golgi complex ( Fig 1D) , whereas the C-terminal domain (Cter-Myc) was distributed throughout the cytosol (Fig 1E) . These results indicate that the Golgi localization of Nir2 is mainly mediated by its PITD. Although Nir2 localizes to the Golgi under steady-state conditions, our previous studies indicate that Nir2 can also be found in other subcellular locations, including the cleavage furrow and midbody during cytokinesis [14] , and lipid droplets under certain metabolic conditions [16] . We noticed that the stimulation of serum-starved HeLa cells with EGF triggered a rapid translocation of endogenous Nir2 to the PM, where it was concentrated in membrane patches (Fig 1F) . Similar results were obtained in MCF7 cells (supplementary Fig S2A online) . WT Nir2-Myc as well as the DPI and the Nir2-Cter mutants were also detected at the PM shortly after EGF stimulation. The DCter mutant and the PITD, however, were retained in the Golgi in both serumstarved and EGF-stimulated HeLa cells (Fig 1G) , suggesting that the C-terminal domain of Nir2 mediates its interaction with the PM in response to EGF stimulation.
PA triggers the PM translocation of Nir2
The C-terminal of Nir2 (aa 911-1244) is a highly conserved region that exhibits a strong sequence similarity (B67%) with the C-terminal regions of its closely related proteins; Nir1 and Nir3, as well as with the Drosophila rdgB homologue (B56%) [17] . This region contains an LNS2 (Lipin/Nde1/Smp2) domain (aa 1,021-1,148 in Nir2; Pfam: PF08235), which was identified in the lipin proteins as an haloacid dehalogenase (HAD)-like domain possessing a Mg 2 þ -dependent PAP activity [18, 19] . The HAD superfamily is one of the largest and most ubiquitous enzyme families, of which ATPases and phosphatases are most prevalent [20] . The HAD superfamily is characterized by three sequence motifs (Fig 2A) : the DXDX(T/V) motif contains an absolutely conserved aspartate residue (underlined) that is critical for the catalytic activity [21] . This motif is conserved within the lipin proteins and is required for their PAP activity [22] . A similar motif is also found in Nir proteins, but the conserved aspartate residue is substituted by a serine (Fig 2A) , suggesting that Nir2 lacks an intrinsic PAP activity, but rather binds to PA.
As Nir2 translocates to the PM in response to EGF through its C-terminal region, and EGF activates PLD, which triggers PA production, we first examined whether exogenous PA can mimic the effect of EGF and induce the translocation of Nir2 to the PM. Serum-starved HeLa cells were treated with PA (100 mM) for 30 min and the localization of endogenous Nir2 was examined by immunofluorescence analysis. As shown, PA could trigger the translocation of endogenous Nir2 to PM patches (Fig 2B) . PA also triggered the translocation of WT Nir2-Myc and its C-terminal region to the PM, but not of the DCter mutant (Fig 2C) . These results indicate that the C-terminal mediates the translocation of Nir2 to the PM in response to both EGF and PA treatments.
To examine whether the translocation of Nir2 to the PM in response to EGF treatment is dependent on PA production, we pretreated serum-starved HeLa cells with 1-butanol, a PLD inhibitor [23] , and then stimulated the cells with EGF. As shown, 1-butanol inhibited the translocation of WT Nir2 and its C-terminal domain to the PM in response to EGF treatment (Fig 2D) , suggesting that EGF induces the production of PA and consequently the PM translocation of Nir2.
The results shown in Fig 2A-D indicate that the C-terminal region of Nir2 can bind to PA. To explore this possibility, we expressed the C-terminal region of Nir2 as a recombinant protein in bacteria, and examined its ability to bind to PA in vitro by liposome sedimentation assays. The recombinant purified His-tagged protein was incubated with multilamellar vesicles consisting of PC alone, or PC and either PA, PS or PIns mix as indicated. Binding was observed only to liposomes containing PA (Fig 2E) . The binding was saturated at 20-25% PA (Fig 2F) and was not influenced by increasing the salt concentration of up to 300 mM (Fig 2G) . A weak binding to PI4P, but not to PI(4,5)P2, was also detected possibly due to the monophosphate group common to both PA and PI4P (Fig 2H) . These observations imply that the LNS2 domain that is known to bind a phosphoryl-group [20] mediates the PA binding in Nir2.
Nir2 modulates EGFR-mediated signalling pathways
The translocation of Nir2 to the PM in response to EGF treatment implies that Nir2 participates in EGFR signalling. We, therefore, examined the influence of Nir2 overexpression or its downregulation by short hairpin RNA (shRNA) on EGFR-mediated downstream signals in HeLa (Fig 3) and MCF7 cells (supplementary Fig S2B online) . Overexpression of Nir2 substantially enhanced the phosphorylation of AKT on both Thr308 and Ser473, but had a minor or no detectable effect on ERK1/2 or p38MAPK phosphorylation, respectively (Fig 3A) . However, downregulation of Nir2 expression markedly reduced the phosphorylation of AKT as well as of ERK1/2. The effect of Nir2 shRNA on ERK1/2 phosphorylation was more profound at 30-120 min following EGF stimulation. Yet, Nir2 depletion had no effect on p38MAPK phosphorylation (Fig 3B) . Similar effects on these downstream pathways were obtained with at least two more RNA that we used previously [15] , possibly due to the higher potency and transient effect of the short interfering RNA.
To better characterize the stimulatory effect of Nir2 overexpression on EGF-induced AKT phosphorylation, we examined the influence of its truncated DPI and DCter mutants. Neither the DPI nor the DCter mutant enhanced the phosphorylation of AKT in response to EGF (Fig 3C) , suggesting that the stimulatory effect of Nir2 on AKT phosphorylation requires both the translocation of Nir2 to the PM and its PI-transfer activity.
Nir2 regulates PI(4,5)P2 and PI(3,4,5)P3 production
The enhanced effects of Nir2 overexpression on AKT phosphorylation, and the inhibitory effects of its shRNA on both AKT and ERK1/2 phosphorylation, indicate that Nir2 regulates several In p u t P C P A P I4 P P I( 4 ,5 )P 2 Nir2 in growth factor-induced signal transduction S. Kim et al scientific report
signalling pathways downstream of EGFR. Phosphorylation of AKT is absolutely dependent on PI(3,4,5)P3 production, whereas ERK1/2 phosphorylation can be activated by several upstream pathways, including the PLCg-mediated PI(4,5)P2 hydrolysis pathway [3] . Inhibition of this pathway by the PLC inhibitor U73122
substantially reduced the phosphorylation of ERK1/2 at 30-120 min following EGF-treatment (Fig 3D) , resembling the effect of Nir2 depletion on ERK1/2 phosphorylation (Fig 3B) . These results indicate that Nir2 regulates the levels of PI (4, (D) Serum-starved HeLa cells were pretreated with the PLCg inhibitor U73122 (10 mM, 30 min), and then stimulated with EGF for the indicated time periods. Total cell lysates were examined for ERK1/2 phosphorylation by WB using anti-pERK1/2 antibody. A.U., arbitrary unit; DMSO, dimethyl sulphoxide; EGF, epidermal growth factor; GFP, green fluorescent protein; IB, immunoblot; PITD, phosphatidylinositol-transfer domain; PM, plasma membrane; shRNA, short hairpin RNA. Nir2 in growth factor-induced signal transduction S. Kim et al scientific report
To monitor the level of PI(3,4,5)P3 in response to EGF stimulation, we used the PH domain of AKT fused to GFP as a reporter [24, 25] . GFP-PH-AKT was visualized in the cytosol and nuclei of serum-starved HeLa cells. EGF treatment triggered a rapid translocation of this reporter to the PM of the control cells; within 1 min GFP-PH-AKT was detected in PM patches. Its PM localization was further enhanced at 3 min, and then slightly declined at 5 min (Fig 4A) . In contrast, the recruitment of GFP-PH-AKT to the PM of Nir2-depleted HeLa cells (Fig 4A) or MCF7 cells (supplementary Fig S2C online) was much less profound at all the examined time points, suggesting that Nir2 positively regulates PI(3,4,5)P3 production in response to EGF stimulation. Indeed, quantitative analysis of EGF-induced PI(3,4,5)P3 production utilizing a competitive enzyme-linked immunosorbent assays clearly showed the inhibitory effect of Nir2 depletion on PI(3,4,5)P3 production (B32 pmol PI(3,4,5)P3/10 7 control cells as compared with B6.5 pmol/10 7 Nir2-depleted HeLa cells at 3 min following EGF treatment; Fig 4B) .
We next examined the level of PI(4,5)P2, a precursor for PI(3,4,5)P3. To monitor the PI(4,5)P2 levels at the PM, we used the PH domain of PLCd fused to GFP as a reporter [26] , and examined its distribution in HeLa cells and in MCF7 cells by live-cell imaging. As shown, GFP-PH-PLCd was localized mainly to the PM of control cells, but could hardly be detected at the PM of Nir2-depleted HeLa cells (Fig 4C) or MCF7 cells (supplementary Fig S2D online) . The relative fluorescence intensity between the PM and the cytosol was B4.5 times higher in the control cells as compared with Nir2-depleted cells (n ¼ 50), suggesting that depletion of Nir2 substantially reduces the PI(4,5)P2 levels at the PM. Immunostaining with anti-PI(4,5)P2 antibodies (Fig 4D) Nir2 in growth factor-induced signal transduction S. Kim et al scientific report
confirmed these results and showed the remarkable effect of Nir2 depletion on PI(4,5)P2 level at the PM. The PI(4,5)P2 level at the PM is regulated by several pathways that control its production and turnover, including its hydrolysis by PLCg. Strikingly, the PLC inhibitor U73122 restored the PI(4,5)P2 level at the PM of Nir2-depleted cells (Fig 4E) , but had no effect on the PI(4,5)P2 level of cells overexpressing the inositol 5-phosphatase Synaptojanin (supplementary Fig S4A online) . These results indicate that Nir2 regulates a PI(4,5)P2 pool that is utilized for PLC hydrolysis. Yet, it could be that depletion of Nir2 accelerates PI(4,5)P2 hydrolysis by PLCg, or alternatively, reduces the production of PI(4,5)P2. In both cases, U73122 would restore the levels of PI(4,5)P2. However, the first possible mechanism predicts an enhanced PLCg-mediated ERK1/2 phosphorylation, whereas our results indicate that depletion of Nir2 attenuates ERK1/2 phosphorylation similarly to the U73122 effect (Fig 3B,D) . Our results, therefore, indicate that Nir2 is essential for maintaining PI(4,5)P2 level at the PM, possibly by positively regulating PI(4,5)P2 production. Indeed, metabolic labelling experiments utilizing [ 32 P]Orthophosphate clearly showed that PI(4,5)P 2 synthesis was significantly reduced (by B28%) in Nir2-depleted HeLa cells (Fig 4F) .
Nir2 regulates PI(4,5)P2 via its lipid transfer/binding capability
To better understand the mechanism by which Nir2 regulates PI(4,5)P2 level at the PM, we examined whether the WT Nir2, its truncated DPI and DCter mutants, as well as the Nir2(S164A) mutant, which apparently lacks a PI/PC-transfer activity in vitro (supplementary Fig S4B online) , could restore the PI(4,5)P2 levels in Nir2-depleted cells. As shown, neither the DPI and the DCter truncated mutants, nor the Nir2(S164A) mutant restored the PI(4,5)P2 level at the PM of Nir2-depleted cells (Fig 5A) . Remarkably, the Nir2(S164A) mutant also did not enhance the phosphorylation of AKT in response to EGF (supplementary Fig S4C online) . Hence, we identified a point mutation (S164A) which is crucial for both PI-transfer activity and for PI(4,5)P2 production. We then asked whether a point mutation that affects PA binding would also impair PI(4,5)P2 production. On the basis of the structural data and conserved motifs in HAD superfamily [20] , we established point mutants of Nir2 within its LNS2 domain: a single mutant D1128A and a triple mutant S1026/D1028/D1128A. As shown, the D1128A mutation substantially reduced the binding of the C-terminal to liposomes containing PA in vitro (Fig 5B) . Furthermore, this point mutation markedly reduced the translocation of Nir2 to the PM in response to either PA or EGF. The effect was even more profound with the triple mutant (Fig 5C) . Most importantly, both the single and the triple mutants failed to restore the PI(4,5)P2 levels at the PM of Nir2-depleted cells (Fig 5D) . These results strongly indicate that both the PI-transfer activity and the translocation of Nir2 to the PM are essential for maintaining PI(4,5)P2 level at the PM. The PI-transfer activity might be required for transport of PI, a precursor of PI(4,5)P2 synthesis, or alternatively, could positively regulate metabolic enzymes that contribute to PI(4,5)P2 synthesis. At present, we are unable to distinguish between these possibilities. Nevertheless, our data strongly indicate that Nir2 positively regulates PI(4,5)P2 and PI(3,4,5)P3 production and their downstream signalling events. Strikingly, rdgB, the Drosophila homologue of Nir2, is also required for PI(4,5)P2 production in response to light. Mutations in rdgB impair PI(4,5)P2 regeneration and cause light-dependent retinal degeneration [27, 28] . Our studies indicate that similarly to Nir2, rdgB is also a dual lipid-binding protein that possibly couples PA to PI(4,5)P2 regeneration during phototransduction. Further studies in flies would clarify this hypothesis.
METHODS
Liposome sedimentation assays. The C-terminal region of Nir2 was expressed as His-tagged protein in bacteria (BL21) and purified on Ni-NTA agarose beads (Qiagen) according to the manufacturer's instructions. Liposome sedimentation assays were performed essentially as described previously [29] , and in supplementary information online. Measurement of PIP 3 content. The PIP 3 content of control and Nir2-depleted HeLa cells was determined by the PIP 3 Mass Elisa Kit (Echelon Biosciences Inc.) according the manufacturer's instructions, as described in supplementary information online. Measurement of PIP2 production. For measuring PIP2 production, control and Nir2-depleted HeLa cells (4 Â 10 6 ) were metabolically labelled for 1 h with 100 mCi [ 32 P]Orthophosphate/ ml (PerkinElmer) in phosphate-free media. Acidic lipids were extracted, separated by thin layer chromatography, visualized by phosphorimager and PI(4,5)P2 synthesis was quantified by densitometry analysis (Image J). Further details are described in supplementary information online. Other methods are described in supplementary information online.
Supplementary information is available at EMBO reports online (http://www.emboreports.org).
